Table 1.
Population characteristics at the time of randomization.
Fig 1.
10-year absolute risk of all-cause death, cardiovascular death, discharge for heart failure, and cardiovascular death or discharge for heart failure.
Abbreviations: PC = primary care, HFC = heart failure clinic, HR = hazard ratio.
Fig 2.
Occurrence of cardiovascular death or discharge for heart failure in subgroups.
Abbreviations: PC = primary care, HFC = heart failure clinic, n = the number of events of the primary outcome, N = the number of patients in the PC or HFC group, CI = confidence interval, NT_proBNP = N-terminal Pro-B-Type Natriuretic Peptide, LVEF = Left ventricular ejection fraction, NYHA = New York Heart Association functional classification, AF = atrial fibrillation, eGFR = estimated glomerular filtration rate, MI = myocardial infarction.
Fig 3.
Adherence to mineralocorticoid receptor antagonists, beta-blockers, and renin-angiotensin system inhibitors in 5-year survivors during the first 5 years of follow-up.
Abbreviations: MRA = mineralocorticoid receptor antagonists, BB = beta blocker, RASi = renin-angiotensin receptor system inhibitors, PC = primary care, HFC = heart failure clinic.